Vascular inflammatory, oxidative and protease-based processes: Implications for neuronal cell death in Alzheimer's disease

Neurological Research

Volumn 26, Issue 5, 2004, Pages 540-546

  Christov, Alexander ^a   Ottman, J Todd ^a   Grammas, Paula ^a  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

Author keywords

Inflammation; Neuronal apoptosis; Oxidative stress; Proteases; Vascular

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; PROTEINASE; REACTIVE OXYGEN METABOLITE; TISSUE PLASMINOGEN ACTIVATOR; TUMOR NECROSIS FACTOR ALPHA;

ALZHEIMER DISEASE; ANIMAL CELL; APOPTOSIS; ARTICLE; BLOOD BRAIN BARRIER; CELL DEATH; ENDOTHELIUM CELL; MEDIATOR RELEASE; MEMBRANE FLUIDITY; NERVE CELL; NEUROTOXICITY; NONHUMAN; OXIDATIVE STRESS; RAT; TARGET CELL; VASCULAR DISEASE;

ALZHEIMER DISEASE; ANIMALS; CELL DEATH; CELL MEMBRANE; CELLS, CULTURED; CEREBRAL ARTERIES; CEREBROVASCULAR DISORDERS; ENDOTHELIAL CELLS; INFLAMMATION; INFLAMMATION MEDIATORS; NERVE DEGENERATION; NEURONS; OXIDATIVE STRESS; PEPTIDE HYDROLASES; RATS; REACTIVE OXYGEN SPECIES; THROMBIN; TISSUE PLASMINOGEN ACTIVATOR; UP-REGULATION;

EID: 3042770549     PISSN: 01616412     EISSN: None     Source Type: Journal    
DOI: 10.1179/016164104225016218     Document Type: Article

References (43)

1. Neuroinflammation Working Group. Inflammation and Alzheimer's disease. Neurobiol Aging 2000; 21: 383-421
2. Tarkowski E. Cytokines in dementia. Curr Drug Targets Inflamm Allergy 2002; 1: 193-200
3. McGeer EG, McGeer PL. Inflammatory processes in Alzheimer's disease. Prog Neuropsycholpharmacol Biol Psychiatry 2003; 27: 741-749
4. Pober JS. Activation and injury of endothelial cells by cytokines. Pathol Biol 1998; 46: 159-163
5. Suo Z, Tan J, Placzek A, et al. Alzheimer's β-amyloid peptides induce inflammatory cascade in human vascular cells: The roles of cytokines and CD40. Brain Res 1998; 807: 110-117
6. Grammas P, Ovase R. Inflammatory factors are elevated in brain microvessels in Alzheimer's disease. Neurobiol Aging 2001; 22: 837-842
7. Grammas P, Ovase R. Cerebrovascular transforming growth factor-β contributes to inflammation in the Alzheimer's disease brain. Am J Pathol 2002; 160: 1583-1587
8. Pereira HA, Kumar P, Grammas P. Expression of CAP37, a novel inflammatory mediator in Alzheimer's disease. Neurobiol Aging 1996; 17: 753-759
9. Minagar A, Long A, Ma T, et al. Interferon (IFN)-beta1a and IFN-beta1b block IFN-gamma induced distintegration of endothelial junction integrity and barrier. Endothelium 2003; 10: 299-307
10. Harkness KA, Sussman JD, Davies-Jones GA, et al. Cytokine regulation of MCP-1 expression in brain and retinal microvascular endothelial cells. J Neuroimmunol 2003; 142: 1-9
11. Grammas P, Ottman T, Reimann-Philipp U, et al. Injured brain endothelial cells release neurotoxic thrombin. J Alzheimer Disease 2004; in press
12. Akiyama, H, Skeda K, Kondo H, et al. Thrombin accumulation in brains of patients with Alzheimer disease. Neurosci Lett 1992; 46: 152-154
13. Smirnova IV, Zhang SX, Citron BA, et al. Thrombin is an extracellular signal that activates intracellular death protease pathways inducing apoptosis in model motor neurons. J Neurobiol 1998; 36: 64-80
14. Turgeon VL, Milligan CE, Houenou LJ. Activation of the protease-activated thrombin receptor (PAR)-1 induces motoneuron degeneration in the developing avian embryo. J Neuropathol Exp Neurol 1999; 58: 499-504
15. Reimann-Philipp U, Ovase R, Weigel PH, et al. Mechanisms of cell death in primary cortical neurons and PC12 cells. J Neurosci Res 2001; 64: 654-660
16. Dorheim MA, Tracey WR, Pollock JS, et al. Nitric oxide is elevated in Alzheimer's brain microvessels. Biochem Biophys Res Commun 1994; 205: 659-665
17. Aliev G, Smith MA, Seyidov D, et al. The role of oxidative stress in the pathophysiology of cerebrovascular lesions in Alzheimer's disease. Brain Pathol 2002; 12: 21-35
18. Floyd RA, Hensley K. Oxidative stress in brain aging. Implications for therapeutics of neurodegenerative diseases. Neurobiol Aging 2002; 23: 795-807
19. Diglio CA, Liu W, Grammas P, et al. Isolation and characterization of cerebral resistance vessel endothelium in culture. Tissue Cell 1993; 25: 833-846
20. Grammas P, Moore P, Weigel PH. Alzheimer's disease brain microvessels kill neurons in vitro. Am J Pathol 154: 337-342, 1999
21. Christov A, Hamdheydari L, Grammas P. Detection of reactive oxygen species by flow cytometry. In: Hensley K, Floyd RA, eds. Methods in Pharmacology and Toxicology: Methods in Biological Oxidative Stress, Humana Press Inc., 2003: pp. 175-184
22. Zalai CV, Kolodziejczyk MD, Pilarski L, et al. Increased circulating monocyte activation in patients with unstable coronary syndromes. J Am Coll Cardiol 2001; 38: 1340-1347
23. Scali C, Giovannini MG, Prosperi C, et al. The selective cyclooxygenase-2 inhibitor rofecoxib suppresses brain inflammation and protects cholinergic neurons from excitotoxic degeneration in vivo. Neuroscience 2003; 117: 909-919
24. McGeer PL, Schulzer M, McGeer EG. Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease: A review of 17 epidemiologic studies. Neurology 1996; 47: 425-432
25. Hull M, Fiebich BL, Schumann G, et al. Anti-inflammatory substances - a new therapeutic option in Alzheimer's disease. Drug Discov Today 1999; 4: 275-282
26. Halliday G, Robinson SR, Shepherd C, et al. Alzheimer's disease and inflammation: A review of cellular and therapeutic mechanisms. Clin Exp Pharmacol Physiol 2000; 27: 1-8
27. Tarkowski E, Andreasen N, Tarkowski A, et al. Intrathecal inflammation precedes development of Alzheimer's disease. J Neurol Neurosurg Psychiatry 2003; 74: 1200-1205
28. Delgado M, Ganea D. Vasoactive intestinal peptide prevents activated microglia-induced neurodegeneration under inflammatory conditions: potential therapeutic role in brain trauma. FASEB J 2003; 17: 1922-1924
29. Hirsch EC, Breidert T, Rousselet E, et al. The role of glial reaction and inflammation in Parkinson's disease. Ann NY Acad Sci 2003; 991: 214-228
30. Eckert A, Keil U, Marques CA, et al. Mitochondrial dysfunction, apoptotic cell death, and Alzheimer's disease. Biochem Pharmacol 2003; 15: 1627-1634
31. Bazan NG, Colangelo V, Lukiw WJ. Prostaglandins and other lipid mediators in Alzheimer's disease. Prostaglandins Other Lipid Mediat 2002; 68-69: 197-210
32. Emerit J, Edeas M, Bricare F. Neurodegenerative diseases and oxidative stress. Biomed Pharmacolther 2004; 58: 39-46
33. Butterfield DA. Amyloid beta-peptide (1-42)-induced oxidative stress and neurotoxicity: Implications for neurodegeneration in Alzheimer's disease brain. A review. Free Radical Res 2002; 36: 1307-1313
34. Prasad KN, Cole WC, Prasad KC. Risk factors for Alzheimer's disease: Role of multiple antioxidants, non-steroidal anti-inflammatory and cholinergic agents alone or in combination in prevention and treatment. J Am Coll Nutr 2002; 21: 506-522
35. Qin L, Liu Y, Wang T, et al. NADPH oxidase mediates lipopolysaccharide- induced neurotoxicity and proinflammatory gene expression in activated microglia. J Biol Chem 2004; 279: 1415-1421
36. Luo X, Weber GA, Zheng J, et al. C1q-calreticulin induced oxidative neurotoxicity: Relevance for the neuropathogenesis of Alzheimer's disease. J Neuroimmunol 2003; 135: 62-71
37. Valencia A, Moran J. Role of oxidative stress in the apoptotic cell death of cultured cerebellar granule neurons. J Neurosci Res 2001; 64: 284-297
38. Banner CDB, Nixon RA, Proteases and protease inhibitors in Alzheimer's disease pathogenesis. Ann NY Acad Sci 1992; 674: 1-259
39. Siao CJ, Tsirka SE. Extracellular proteases and neuronal cell death. Cell Mol Biol 2002; 48: 151-161
40. Melchor JP, Pawlak R, Chen Z, et al. The possible role of tissue-type plasminogen activator (tPA) and tPA blockers in the pathogenesis and treatment of Alzheimer's disease. J Mol Neurosci 2003; 20: 287-289
41. Suo Z, Wu M, Citron BA, et al. Rapid tau aggregation and delayed hippocampal neuronal death induced by persistent thrombin signaling. J Biol Chem 2003; 278: 37681-37689
42. Abe Y, Nakamura H, Yoshino O, et al. Decreased neural damage after spinal cord injury in tPA-deficient mice. J Neurotrauma 2003; 20: 43-57
43. Gabriel C, Ali C, Lesne S, et al. Transforming growth factor alpha-induced expression of type 1 plasminogen activator inhibitor in astrocytes rescues neurons from excitotoxicity. FASEB J 2003; 17: 277-279